Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical activity after 12 weeks of treatment with nonbiologics in early rheumatoid arthritis may predict articular destruction 2 years later.
Ichikawa Y, Saito T, Yamanaka H, Akizuki M, Kondo H, Kobayashi S, Oshima H, Kawai S, Hama N, Yamada H, Mimori T, Amano K, Tanaka Y, Matsuoka Y, Yamamoto S, Matsubara T, Murata N, Asai T, Suzuki Y; Study Group for the Japanese Ministry of Health, Labor and Welfare, Research for Establishment of Therapeutic Guidelines in Early Rheumatoid Arthritis Program. Ichikawa Y, et al. Among authors: yamamoto s. J Rheumatol. 2010 Apr;37(4):723-9. doi: 10.3899/jrheum.090776. Epub 2010 Mar 1. J Rheumatol. 2010. PMID: 20194455 Clinical Trial.
Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study.
Ichikawa Y, Saito T, Yamanaka H, Akizuki M, Kondo H, Kobayashi S, Oshima H, Kawai S, Hama N, Yamada H, Mimori T, Amano K, Tanaka Y, Matsuoka Y, Yamamoto S, Matsubara T, Murata N, Asai T, Suzuki Y; MTX-BUC Combination Study Group; Japanese Ministry of Health; Labour and Welfare's "Research for Establishment of Therapeutic Guidelines in Early Rheumatoid Arthritis". Ichikawa Y, et al. Among authors: yamamoto s. Mod Rheumatol. 2005;15(5):323-8. doi: 10.1007/s10165-005-0420-z. Mod Rheumatol. 2005. PMID: 17029087
Possibility of hypoalbuminemia itself as a risk for clinical failure.
Sumiyoshi S, Yamamoto S. Sumiyoshi S, et al. Among authors: yamamoto s. Antimicrob Agents Chemother. 2024 Apr 17:e0036724. doi: 10.1128/aac.00367-24. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 38629859 No abstract available.
Extracellular vesicles and prostate cancer management: a narrative review.
Urabe F, Yamada Y, Yamamoto S, Tsuzuki S, Kimura S, Ochiya T, Kimura T. Urabe F, et al. Among authors: yamamoto s. Transl Androl Urol. 2024 Mar 31;13(3):442-453. doi: 10.21037/tau-23-533. Epub 2024 Mar 20. Transl Androl Urol. 2024. PMID: 38590964 Free PMC article. Review.
Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study.
Sakaguchi T, Mitsuke A, Osako Y, Yamada Y, Takeyama H, Ogawa R, Takahashi K, Hirohata Y, Yamamoto S, Arima J, Fukumoto W, Sugita S, Inoguchi S, Matsushita R, Yoshino H, Tatarano S, Enokida H. Sakaguchi T, et al. Among authors: yamamoto s. BMC Nephrol. 2024 Apr 8;25(1):124. doi: 10.1186/s12882-024-03561-7. BMC Nephrol. 2024. PMID: 38589827 Free PMC article.
Fourth national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from patients with complicated urinary tract infections.
Kobayashi K, Takahashi S, Yasuda M, Miyazaki J, Wada K, Matsumoto M, Hayami H, Yamamoto S, Kiyota H, Sato J, Matsumoto T, Hasegawa N, Kobayashi I, Masumori N, Kimura T, Yamada H, Nakagawa T, Kaneko T, Matsumoto K, Fujimura T, Kamei J, Ishikawa K, Fujimoto K, Nakai Y, Shigemura K, Sadahira T, Hinata N, Kitano H, Yamashita M, Yasufuku T, Komeda H, Hiyama Y, Takahashi Y, Kanamaru S, Murakami M, Arakawa S, Yamada D, Mita K, Hamasuna R, Tanaka K, Matsukawa M, Takaoka E, Shigeta M, Takenaka T, Nishino M, Ishitoya S, Hayakawa S, Okumura K, Ueda M. Kobayashi K, et al. Among authors: yamamoto s. J Infect Chemother. 2024 Apr 6:S1341-321X(24)00108-9. doi: 10.1016/j.jiac.2024.03.024. Online ahead of print. J Infect Chemother. 2024. PMID: 38588797
Blood pressure classification using the Japanese Society of Hypertension Guidelines for the Management of Hypertension and cardiovascular events among young to middle-aged working adults.
Kuwahara K, Ohkubo T, Inoue Y, Honda T, Yamamoto S, Nakagawa T, Okazaki H, Yamamoto M, Miyamoto T, Gommori N, Kochi T, Ogasawara T, Yamamoto K, Konishi M, Kabe I, Dohi S, Mizoue T. Kuwahara K, et al. Among authors: yamamoto s. Hypertens Res. 2024 Apr 8. doi: 10.1038/s41440-024-01653-3. Online ahead of print. Hypertens Res. 2024. PMID: 38584158
10,287 results
You have reached the last available page of results. Please see the User Guide for more information.